The University of Birmingham and Acticor Biotech announce
University of Birmingham and Acticor Biotech News ReleaseLimited clinical access available The University of Birmingham and Acticor Biotech announce...
Stay updated with breaking news from Jon Townend. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
University of Birmingham and Acticor Biotech News ReleaseLimited clinical access available The University of Birmingham and Acticor Biotech announce...
September 7th, 2023, the University of Birmingham and Acticor Biotech announce the full regulatory approval of LIBERATE clinical study.
A potential new drug to improve the long-term outcomes for heart attack patients will be trialled in the UK. With the signing of a partnership between the University of Birmingham and Acticor Biotech, a new clinical trial called LIBERATE will take place in two acute care hospitals in the UK: the Queen Elizabeth ...
Acticor Biotech's glenzocimab, a potential new drug to improve the long-term outcomes for heart attack patients will be trialed in the U.K.
The first clinical trial for new heart attack drug glenzocimab, will evaluate its ability to reduce heart damage following a heart attack.